Clinicopathological features and survival outcomes of CD30 expression in extranodal natural killer/T-cell lymphoma

Online journal article in Hematopathology that offers 1.0 continuing education (CME) credit that can be used to fulfill CC Part II requirements.

Quantity:

Want to save more?

Log into see if you qualify for a lower rate.

Members

save $5.00 or more

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Describe the role of CD30 in cell-signaling and the settings in which it may be expressed on the surfaces of lymphocytes.
Discuss the prognostic...

Intended Audience: Pathologists, Residents, Clinical Scientists, Pathologist Assistants

Upon completion of this activity, you will be able to:

Describe the role of CD30 in cell-signaling and the settings in which it may be expressed on the surfaces of lymphocytes.
Discuss the prognostic implications of CD30 expression or absence of expression in patients with extranodal natural killer/T-cell lymphoma.
List statistical analytical tools to apply to data sets to correlate prognosis with marker expression and to determine optimal cut-offs for levels of marker expression.

View More View Less